Research Associate / Scientist – Metabolic Conditions


Moonwalk Biosciences is recruiting for Research Associate / Scientist position to join the R&D team focused on metabolic conditions including obesity and NASH. In this role, you will work closely within the R&D team to conduct biological and translational research in the area of metabolic conditions, working closely with the platform technology team to leverage Moonwalk’s epigenome engineering platform.


  • Design and implement experiments, troubleshoot technical issues, and independently conduct scientific research to identify and validate targets and determine their mechanism of action.
  • Establish critical laboratory capabilities for design and implementation of studies.
  • Close collaboration within the R&D team to achieve project objectives.
  • Detailed documentation and presentation of protocols and data.

Required Qualifications:

  • M.S./PhD in cell biology, biochemistry, pharmacology, or equivalent with 3+ years of relevant experience.
  • Demonstrated expertise to develop disease relevant in-vitro assays for metabolic conditions using cell lines, primary cells, and animal models.
  • Proficiency in cell culture techniques, including primary cell isolation, cell line maintenance, and culture.
  • Strong molecular biology skills, including qPCR, western blotting, immunofluorescence, flow cytometry, and gene editing techniques (e.g., CRISPR/Cas9).
  • Experience with genetic engineering and cellular payload delivery including transduction and transfection is preferred.
  • Strong attention to detail and impeccable organizational and documentation skills.
  • Ability to excel in a team-first, supportive work environment, and clearly articulate ideas, problems, and solutions.
  • Ability to thrive in early stage technology development with demanding schedules and deliverables.

About Moonwalk Biosciences:

Moonwalk Biosciences is pioneering a new class of precision epigenetic medicines. Its novel platform technology provides a complete view of the epigenome in health and disease, with the most advanced AI prediction of epigenetic targets, and the broadest set of epigenetic engineering tools. Moonwalk was co-founded by Alex Aravanis, M.D., Ph.D., former CTO of Illumina, world-renowned scientist Feng Zhang, Ph.D. of the Broad Institute of MIT and Harvard, and a distinguished set of industry leaders and company builders. It has raised $57 million led by Alpha Wave Ventures, and joined by other leading life sciences investors ARCH Venture Partners, Future Ventures, GV, Khosla Ventures and YK Bioventures.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.